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The development of new approaches leading to fast and successful vascularization of tissue-
engineered constructs is one of the most intensively studied subjects in tissue engineering and 
regenerative medicine. Recently, TLR4 activation and LPS stimulation of endothelial cells have 
been reported to promote angiogenesis in a variety of settings.  In this study, we demonstrate that 
TLR4 activation by Ultrapure LPS E. coli 0111:B4 (LPS-EB) significantly enhances microvessel 
formation in a coculture system consisting of outgrowth endothelial cells (OECs) and primary 
human osteoblasts (pOBs). The precise modes of TLR4 action on the process of angiogenesis 
have also been investigated in this study. By using quantitative fluorescence microscopy in 
monocultures of OEC and pOBs it was found that TLR4 activation through LPS-EB upregulates 
the expression level of TLR4/MYD88 and enhances both angiogenesis and osteogenesis. 
Furthermore, ELISA and qRT-PCR have shown that the level of two adhesion molecules (ICAM-
1, E-selectin), two cytokines (IL-6 and IL-8), and two growth factors (VEGF, PDGF-BB) related 
to angiogenesis increase significantly after LPS-EB treatment. This increased understanding of 
the role of TLR4 in angiogenesis could be of value in various settings related to tissue repair and 
tissue engineering. Moreover, since LPS and TLR4 agonists improve angiogenesis and 
osteogenesis, TLR4 agonists (endogenous or synthetic) could be used for angiogenesis 
intervention in vivo and therefore could be tested for their potential clinical applications in 
promoting angiogenesis in bone tissue engineering. 
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The creation of functional tissue constructs and other therapeutic products in tissue engineering 
and regenerative medicine is a highly challenging task. Adequate vascularization of tissue-
engineered constructs is an important prerequisite and could be promoted by inducing stem cells 
or progenitor cells to reach the site of injury/replacement for tissue repair (Lapidot et al., 2005; 
Pelosi et al., 2002).  The development of new approaches leading to fast and successful 
vascularization is therefore one of the most intensively studied subjects in the field of tissue 
engineering and regenerative medicine (Moon and West, 2008; Cenni et al., 2011).  Our previous 
studies demonstrated that endothelial progenitor cells from human peripheral blood or cord blood 
are a potential autologous cell source for cellular therapies aimed at enhancing the 
neovascularization of tissue-engineered constructs (Fuchs et al., 2010; Ghanaati et al., 2011; 
Kolbe et al., 2011; Dohle et al., 2011). However, in these in vitro angiogenesis studies the effect 
of one important system present in vivo, namely the immune system, has not been taken into 
account.  
The mammalian immune system consists of two integrated components, the innate and the 
adaptive systems, whose principal functions are to defend the host against infection by various 
pathogens (Beutler, 2004). Recently, it has been shown that the innate immune system also plays 
an important role in tissue engineering and regenerative medicine (Sefton et al., 2008). Following 
biomaterial implantation, host reactions can include tissue injury, blood-material interactions, 
provisional matrix formation, acute and chronic inflammation, granulation-tissue development, 
foreign-body reaction, and fibrosis/fibrous capsule development (Morais et al., 2010). Several 
studies have recently linked innate immunity to biomaterial implantation (Schmidt et al., 2010; 




Innate immune recognition relies on a diverse set of germ-line-encoded receptors, termed pattern 
recognition receptors (PRR), which bind broad classes of molecular structures common to groups 
of microorganisms (Takeuchi and  Akira 2010). Toll-like receptors (TLRs), which are related to 
the Toll protein of Drosophila, are one of the largest and best-studied families of PRR (Akira and 
Takeda, 2004). Following the recognition of pathogen-associated molecular patterns (PAMP) of 
microbial origin, the TLRs alert the immune system and initiate innate and adaptive immune 
responses (Akira and Takeda, 2004). However, the TLR system is not confined solely to 
leukocyte-mediated immune defense against exogenous pathogens. In addition to myeloid cells, 
TLR expression has been reported in many tissue and cell types (Cho et al., 2007; Kikuchi et al., 
2001; Edelman et al., 2007; Zimmer et al., 2011).  Moreover, despite the microbial patterns that 
are commonly accepted as TLR ligands, increasing evidence indicates that TLRs also recognize 
host-derived molecules (Yu et al., 2010).  
Recent studies have demonstrated that TLR activation promotes angiogenesis in various 
inflammatory settings in response to both exogenous and endogenous ligands, although the 
precise mode of action of TLRs in this context remains ambiguous (Cho et al., 2007; Grote et al., 
2010; Varoga et al., 2006; West et al., 2010; Kanzler et al., 2007). In our previous work, we 
demonstrated that the coculture of human outgrowth endothelial cells (OECs) isolated from the 
mononuclear cell fraction of peripheral blood with primary human osteoblasts (pOBs) results in 
the formation of perfused vascular structures in vitro and in vivo (Fuchs et al., 2010; Ghanaati et 
al., 2011; Dohle et al., 2011). Since TLRs are expressed on a variety of cells, including 
fibroblasts (Cho et al., 2007), osteoblasts (Kikuchi et al., 2001), pericytes (Edelman et al., 2007), 
and endothelial cells (Zimmer et al., 2011), an investigation of the role of TLR signaling in 
angiogenesis/vascularization is of great interest in the context of tissue engineering and 
biomaterial implantation. The activation or blockade of TLR signaling pathways, using 
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techniques that have been applied in therapeutic approaches for some diseases (Kanzler et al., 
2007), might also be used to promote angiogenesis/vascularization. Among the TLRs we focussed 
on TLR4, whose activation has been reported to play a role in angiogenesis (He et al., 2013; 
Jagavelu et al., 2010).  The goal of this study was to investigate the mechanisms by which TLR4 
signaling pathways affect angiogenesis and tissue regeneration in a coculture system of OECs 
and pOBs and to develop potential approaches to promote the vascularization of tissue constructs 
for applications in tissue engineering and regenerative medicine. 
2. Materials and methods 
2.1. OEC and pOB cultures 
Mononuclear cells were isolated from human peripheral blood buffy coats by Ficoll/histopaque 
(Sigma-Aldrich, Seelze, Germany) density gradient centrifugations. OECs were then prepared 
from these mononuclear cells and characterized as previously described (Herzog et al., 2014).   
pOBs were isolated from human bone fragments from healthy donors according to an established 
protocol approved by the responsible Ethical Commission (Herzog et al., 2014).  pOBs of 
passage 2 to 5 from several donors and OECs of passage 8 to 18 from 3 donors were used for the 
study. 
For stimulation experiments, OECs or pOBs seeded on 13 mm, rat tail collagen type-I (BD 
Biosciences, Heidelberg, Germany)-coated glass coverslips (Gerhard Menzel, Braunschweig, 
Germany) in 24-well culture plates were exposed to 1.25 µg/ml (equal to 1.25x103 EU/ml in data 
sheet) Ultrapure LPS E. coli 0111:B4 (abbreviated as LPS-EB; InvivoGen, Toulouse, France) for 
24 hours and processed for further analysis. This preparation of LPS only activates TLR4 when 
being applied at the concentration range used in this study (Gutschow et al., 2013). 
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2.2 Coculture of OECs and pOBs  
1x105 pOBs/well were seeded on 13 mm rat tail collagen type-I –coated glass coverslips in 24- 
well plates and cultivated in Dulbecco's Modified Eagle Medium (DMEM)-Ham F12 containing 
10% fetal calf serum (FCS) and 1% penicillin/streptomycin (Pen/Strep). After 24 hours, 1x105 
OECs/well were added, and the cells were co-cultivated for 7 days or longer in Endothelial Cell 
Growth Media (EGM)-2 with 5% FCS, 1% pen/strep, and supplements from kits (EGM-2 
BulletKit, Lonza, Basel, Switzerland) before stimulation. 
2.3. LPS treatment of cocultures of pOBs and OECs  
After 7 days of in vitro (DIV7) cocultivation (or longer as described elsewhere), cocultures of 
OECs and pOBs were exposed to LPS-EB at the described concentrations for 24 hours or longer 
if needed. After a change of medium, the cocultures were then processed for gene expression 
analysis and protein/factor analysis. For immunofluorescent staining of microvessels with anti-
CD31, the coculture was cultivated for an additional 3 days. 
2.4. Wound scratch assay 
The tip of a yellow Gilson pipette was used to wound the DIV7 OECs on glass coverslips, 
creating linear defects in the cell layer of about 1 mm breadth. The cells were washed with 
phosphate-buffered saline (PBS) to remove floating cellular debris and re-fed for an additional 24 
hours with EGM medium with and without LPS-EB (1.25µg/ml). After 24 hours, “wound 
closure” in vitro was photographed by using an inverted microscope (20x, Leica DMI 6000B, 
Leica Microsystems, Wetzlar, Germany) equipped with a digital camera (Leica DFC 350FX). 
2.5. Fibrin Gel in vitro Angiogenesis Assay 
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The Fibrin Gel in vitro Angiogenesis Assay Kit was purchased from CHEMICON (Limburg, 
Germany). The assay was performed according to the manufacturer’s instructions and 
recommended volumes of reagents and media were used for 24-well plates:  (a) 200 μl fibrinogen 
solution/well was dispensed in wells of a 24-well plate, and after gentle shaking, 133 μl 
thrombin/well were added, and the plates incubated at 37 ºC for 15 minutes to initiate fibrin 
polymerization; (b) 5x104 OECs in 1 ml EGM medium/well were then added to the fibrin gel; (c) 
after overnight incubation at 37ºC, the medium was removed from the culture, and the steps in (a) 
were repeated to create an additional fibrin layer on top of the cells, following which 1 ml EGM 
medium with and without 1.25 μg/ml LPS-EB was added to each well, and the plate was placed 
back into the 37 ºC incubator; (d) after 24 hours, images were photographed by using an inverted 
microscope (20x, Leica DMI 6000B) equipped with a digital camera (Leica DFC 350FX). 
2.6. Antibodies 
Mouse anti-human CD31 (platelet endothelial cell adhesion molecule (PECAM-1)) and mouse 
anti-Ki67 protein were purchased from DAKO (Hamburg, Germany). Rabbit anti-human TLR4 
was purchased from Antibody Online (Aachen, Germany). Rabbit anti-myeloid differentiation 
primary response gene 88 (MYD88) was obtained from Pierce Antibodies (Rockford, IL, USA). 
Mouse anti-human vascular endothelial growth factor (VEGF) was obtained from Santa Cruz 
Biotechnology (Heidelberg, Germany). Goat anti-angiopoietin 1, goat anti-angiopoietin 2, and 
mouse anti-osteocalcin were purchased from R&D systems (Wiesbaden, Germany). Mouse anti-
osteonectin was obtained from GenWay Biotech (San Diego, CA, USA). 
Alexa Fluor® 546-conjugated goat anti-mouse IgG, Alexa Fluor® 546-conjugated goat anti- 
rabbit IgG, and Alexa Fluor® 594-conjugated donkey anti- goat IgG were purchased from Life 
Technologies (Darmstadt, Germany). 
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2.7. Immunofluorescent staining  
All dilutions and washes (3×5 minutes) between stages were performed in PBS. Cells or 
cocultures on 13 mm glass coverslips were fixed with 4% paraformaldehyde (PFA; Electron 
Microscopy Sciences, Munich, Germany) in PBS for 10 minutes at room temperature. After 
being washed with PBS, the cells were treated with 0.2% Triton X-100 (Sigma) in PBS for 3 
minutes and blocked with antibody dilution buffer (1% Bovine Serum Albumin (BSA, IgG-Free, 
Protease-Free), Jackson ImmunoResearch Europe, Suffolk, UK) in PBS for 20 minutes. The cells 
were then incubated for 1 hour with primary antibodies followed by 45-minute incubation with 
secondary antibodies and/or Phalloidin Control, DyLight 488 conjugate (Pierce Antibodies). For 
nuclear staining, the cells were then incubated with 1, 5-bis {[2-(di-methylamino) ethyl] amino}-
4, 8-dihydroxyanthracene-9, 10-dione (DRAQ5™; New England Biolabs, Frankfurt, Germany) 
for 15 minutes. After being washed with PBS, the coverslips were mounted with fluorescent 
mounting medium (DAKO) upside-down on glass slides (26x76mm, Gerhard Menzel) for 
fluorescence microscopy. 
2.8. Fluorescence microscopy  
Fluorescent imaging was performed by using a Keyence BZ-9000 fluorescence microscope (20x, 
Keyence, Neu-Isenburg, Germany).  Images were acquired and saved in TIFF format. For each 
experiment, all images were acquired and processed by using the same scales and parameters.  
2.9. Analysis of microvessel area 
ImageJ (version 1.45s) was downloaded from the website (http://rsb.info.nih.gov/ij/) of the 
National Institutes of Health (Bethesda, MD, USA). All images in one experiment group were 
processed and analyzed by using the same scales and parameters. (a) Images from fluorescent 
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microscopy were changed to gray-scale and printed on DIN (the German Institute for 
Standardization) A4 paper (this print-out is named P1); (b) carbon paper for typewriting (CPT, 
Pelikan, Hannover, Germany) was put underneath P1, and blank A4 white paper was 
subsequently placed under the CPT; (c) vessels were traced manually by drawing their outlines 
on P1, and the outlines of vessels were "copied" onto blank A4 paper (this paper is named P2) by 
CPT; (d) the vessel contours on P2 were then filled with magenta color by using a magenta color 
marker, P2 was subsequently scanned by using an HP Officejet Pro 8500 A910 Color Scanner 
(Hewlett-Packard, Böblingen, Germany), and  scanned images were saved as TIFF files; (e)  
images were imported into ImageJ, and the vessels were segmented by using the “Color 
threshold" function in the "Adjust" submenu of  " Image" menu; (f) the  vessel area was measured 
by using the "Analyze particles" function in the "Analyze" menu. Small objects such as dirt 
particles on the paper were filtered by setting the particle size to be analyzed. Only objects larger 
than 500 square-pixels were selected for analysis. Parameters of vessels were imported into MS-
Excel (Microsoft Office; Microsoft) for further analysis. Steps in (e) and (f) were performed in a 
batch mode in ImageJ. 
2.10. Analysis of the intensity index 
The analysis was performed with ImageJ. All images in one experiment group were processed 
and analyzed by using the same scales and parameters. Actin staining by Alexa Fluor®488 
Phalloidin was used as normalization factor reflecting the biomass of cells in defined areas of 
monocultures of OECs or pOBs.  The intensity index was calculated by using the equation: 
Intensity Index = Intensity of target staining/Intensity of actin staining x100. For each 
experiment, three images from each culture were acquired and analyzed. Parameters obtained 
from ImageJ were imported into MS-Excel for further analysis. 
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2.11. Enzyme-linked immunosorbent assay (ELISA) 
 The supernatant of DIV7 cocultures of OECs and pOBs were used for the analysis.  ELISA was 
carried out according to the manufacturer's recommendations (R&D Systems) as previously 
described (Li et al., 2013).   Reagents for intercellular adhesion molecule 1 (ICAM-1; CD54), E-
selectin, interleukin-6 (IL-6), and IL-8 for the ELISA DuoSets® kits were purchased from R&D 
Systems. 
2.12. Quantitative real-time polymerase chain reaction (qRT-PCR) 
qRT-PCR was performed as previously described (Li et al., 2013).   The sequences for qRT-PCR 
primers were as follows: VEGF forward 5' CGA GGG CCT GGA GTG TGT 3'; VEGF reverse 5' 
CCG CAT AAT CTG CAT GGT GAT 3'; PDGF-BB forward 5' GAT CCG CTC CTT TGA 
TGA TCT 3'; PDGF-BB reverse 5' TCC AAC TCG GCC CCA TCT 3'. These primers and 
primers for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) were provided by Qiagen 
(Hilden, Germany).  
2.13. Statistical analysis  
MS-Excel was used for statistical analysis. Statistically significant differences were evaluated by 
using the paired Student's t-test (p-value *p<0.05 and **p<0.01). Data are expressed as mean 







3.1. LPS-EB stimulation enhances the formation of capillary-like structures in coculture 
system of pOBs and OECs 
 To investigate the effects of TLR4 signaling on the formation of capillary-like structures in the 
cultures, we used a specific type of LPS-EB. This ultrapure LPS, which is extracted by 
successive enzymatic hydrolysis steps and purified by the phenol-triethylamine-deoxycholate 
sodium (TEA-DOC) extraction protocol, only activates the TLR4 pathway and is therefore highly 
suitable for our study. DIV7 cocultures of pOBs and OECs were treated with 1.25 µ/ml LPS-EB 
for 24 hours, cultivated for an additional 3 day period, and stained for the endothelial marker 
CD31. Quantitative fluorescence microscopy has been used more and more widely in the analysis 
of proteins and genes in biological samples (Ma et al., 2012) and in this study we used it for the 
quantitative analysis of vessel area and other factors. We observed that the LPS-EB treatment 
enhanced the formation of capillary-like structures in cocultures of pOBs and OECs significantly 
(Figure 1A). To check whether this effect was concentration-dependent, cocultures were treated 
with various concentrations of LPS-EB; the results are shown in Figure 1B-C. In all treated 
cocultures, significant enhancement of microvessel formation was seen when compared with 
corresponding control cocultures.  
We next checked the effect of longer LPS-EB treatment on angiogenesis in the coculture system. 
DIV7 cocultures of pOBs and OECs were treated with 1.25 µg/ml LPS-EB for 96 hours and 
cultivated for an additional 3 days prior to CD31 staining. The results are shown in Figure 1D. 
Significant enhancement of microvessel formation was seen compared with control cocultures. 
However, the stimulation effect was not as strong as that observed in the 24-hour treatment 
groups (Figure 1A-C). 
3.2. LPS-EB treatment has positive effects on OEC activities related to angiogenesis 
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To study the mechanism by which TLR4 stimulation enhanced microvessel formation, we 
investigated first the effect of LPS-EB stimulation on the monocultures of OECs. Typical results 
of TLR4 staining of DIV7 OECs are shown in Figure 2A. All OECs expressed the endothelial 
cell marker CD31, and TLR4 staining was observed on the cell membrane and in the cytoplasm 
of OECs. Expression of TLR4 was observed at other DIV stages of the cultures (data not shown). 
After a 24-hour treatment with 1.25 µg/ml LPS-EB, the expression level of TLR4 on OECs 
increased significantly (Figure 2B). In addition, MYD88, an adapter protein that activates the 
transcription factor, nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB) in 
TLR4 signaling, was also upregulated in OECs (Figure 2B).  
Several positive effects on OEC activities related to angiogenesis were also observed. First, LPS-
EB treatment enhanced OEC proliferation, which was demonstrated by comparing Ki67 staining 
in OEC monocultures without and with LPS-EB treatment (Figure 2C).  Second, the wound 
scratch assay revealed that the LPS-EB treatment also enhanced the directed cell migration of 
OECs (Figure 2D). Third, LPS-EB treatment on OEC also affected the cell biology related to 
angiogenesis. The Fibrin Gel in vitro Angiogenesis Assay was applied to evaluate this effect. The 
results are shown in Figure 3A. After a 24-hour treatment with 1.25 µg/ml LPS-EB, tube 
formation was observed in OECs of LPS-EB-treated groups, whereas the control group exhibited 
no obvious tube formation. Fourth, LPS-EB treatment also upregulated significantly the 
expression levels of VEGF and another two important angiogenic factors, namely angiopoietin 1 
and angiopoietin 2, in OEC monocultures (Figure 3B and Supplementary Figure 1).  
Reorganization of actin filaments is also an important process during angiogenesis (Lamalice et 
al., 2007).   In this study, we observed that the TLR4 ligand LPS-EB also altered the organization 
of actin filaments in OECs. The results are shown in Figure 4A-B. Various manifestations of 
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reorganization of actin filaments, such as peripheral accumulation, stress fiber formation, knotted 
form staining, spike and filopodia formation, as well as F-actin depolymerization in certain areas 
were observed in OECs after LPS-EB treatment. 
3.3. LPS-EB treatment upregulates TLR4 and osteogenic markers in pOBs 
Typical staining results of TLR4 on DIV5 pOBs are shown in Figure 5A and Supplementary 
Figure 2. TLR4 staining was observed on the cell membrane and in the cytoplasm of pOBs. 
Expression of TLR4 on pOBs was also observed at other DIV stages of the cultures (data not 
shown). After a 24-hour treatment with 1.25 µg/ml LPS-EB, the expression levels of TLR4 and 
MYD88 increased significantly (Figure 5B). We also observed that LPS-EB treatment enhanced 
OEC proliferation, which was demonstrated by comparing Ki67 staining in pOB monocultures 
without and with LPS-EB treatment (Figure 5C).  To study the effect of LPS-EB treatment on 
osteogenesis, pOBs were treated with 1.25 µg/ml LPS for 24 hours and stained for two important 
osteogenic factors, namely osteocalcin and osteonectin. The results are shown in Figure 5D. The 
expression levels of osteocalcin and osteonectin increased significantly after LPS-EB treatment.  
3.4. LPS-EB treatment upregulates inflammatory and angiogenic factors in cocultures 
To analyze the molecular mechanisms leading to angiogenic and osteogenic activation via the 
LPS-EB treatment of the cocultures, several structural components and inflammatory factors 
related to the process of angiogenesis were analyzed. The supernatant of DIV7 cocultures of 
OECs and pOBs were used for ELISA and the results are shown in Figure 6A. We observed that 
the expression levels of ICAM-1 and E-selectin, which induced angiogenesis and supported the 
survival of microvessels, increased significantly after 24 hours of LPS-EB treatment. In addition, 
the expression levels of two cytokines, namely IL-6 and IL-8, which play important roles in 
endothelial cell survival and exert pro-angiogenic effects on endothelial cells, were also 
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upregulated significantly after 24 hours of LPS-EB treatment. In addition, by using qRT-PCR, we 
found that the levels of VEGF and PDGF-BB in the cells of cocultures were upregulated after 24 
hours of LPS treatment (Figure 6B). 
4. Discussion 
TLR4 activation and LPS stimulation of endothelial cells have recently been reported to promote 
angiogenesis in a variety of settings (Jagavelu et al., 2010; Pollet et al., 2003). In this study, we 
have demonstrated that TLR4 activation in response to the exogenous TLR4 ligand LPS-EB 
promotes angiogenesis in a coculture system consisting of OECs and pOBs. Since this LPS-EB 
preparation only activates TLR4, our data further support the concept in which TLR4 activation 
by both exogenous and endogenous ligands alters endothelial cell function and promotes 
angiogenesis. In addition, the precise modes of TLR4 action on the process of angiogenesis have 
been investigated by using the cocultures and monocultures of OEC/pOB, separately. 
4.1. TLR4 signaling in the OECs 
Recently, it has been shown that not only macrophages, but also resident smooth muscle and 
endothelial cells, contribute to vascular inflammation and dysfunction (Edelman et al., 2007; 
Zimmer et al., 2011; Hickey and Kubes, 2009). In the present study we show that OECs are 
immune-competent cells that can actively participate in innate immunity. All CD31+ cells express 
TLR4, and the staining patterns are similar to those of some previously reported studies (Jagavelu 
et al., 2010; Kang et al., 2009).  LPS-EB stimulation of TLR4 significantly upregulates the 
expression of TLR4 and its adapter protein MYD88 on OECs. Although OECs are negative for 
CD14 (Medina et al., 2010), a co-receptor for LPS, the TLR4 signalling can be initiated through a 
MYD88-dependent pathway instead of the TLR4/TRAM-TRIF pathway (MYD88-independent, 
CD14 is needed; Jiang et al., 2005). This stimulatory effect has been observed by using various 
15 
 
concentrations of LPS-EB (from ng/ml to µg/ml, latter data not shown). Immunostaining and the 
wound scratch assay also demonstrated that this stimulation improves OEC proliferation and 
directional migration, two important steps in angiogenesis/vasculogenesis.  
VEGF (a subfamily of PDGF) and the angiopoietins (members of a family of vascular growth 
factors) cooperatively orchestrate the individual steps during new vessel formation and 
stabilization in development and repair (Asahara et al., 1998).   VEGF can induce pro-angiogenic 
activation of endothelial cells, and this activation is facilitated by angiopoietin-2, leading to the 
destabilization of cell–cell and cell–matrix interactions in endothelial cells. These steps are 
crucial in the angiogenesis process (Asahara et al., 1998). It also has been reported that 
angiopoietin-2 promotes angiogenesis through integrin signaling instead of TIE2 signaling 
(Felcht et al., 2012). In addition, the stabilization of the vessels can be promoted by angiopoietin-
1 through the recruitment of other resident cells such as smooth muscle cells (Suri et al., 1998). In 
this study, several findings are related to the angiogenesis potential of OECs. First, after LPS-EB 
stimulation, the amount of VEGF in OECs increases significantly. Second, the expression level 
of angiopoietin-1 increases after LPS-EB regulation. Third, the OECs also expressed 
angiopoietin-2, and its level is significantly upregulated after LPS-EB treatment. Fourth, LPS-EB 
stimulation has effects on OECs and their actin filament reorganization, which is also an 
important process in angiogenesis (Lamalice et al., 2007). All these findings demonstrate that 
TLR4 activation through LPS-EB at the designated concentrations can improve the angiogenic 
potential/capabilities of OECs.  
4.2. TLR4 signaling in the pOBs 
Recent studies have suggested that osteoblasts are also immune competent and can actively 
participate in innate immunity (Stanley et al., 2006). Bone cells are now known to express TLRs 
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(Kikuchi et al., 2001; Stanley et al., 2006). In the present study, pOBs expressed TLR4, and the 
expression level was upregulated after LPS-EB treatment. This stimulation effect was observed 
by using various concentrations of LPS-EB (from ng/ml to µg/ml, latter data not shown). In 
addition, immunostaining demonstrated that this stimulation also improves the proliferation of 
pOBs, another important step in osteogenesis.  Furthermore, two crucial osteogenesis markers, 
namely osteocalcin and osteonectin, are upregulated after a 24-hour LPS-EB treatment. All these 
findings demonstrate that TLR4 activation through LPS-EB at the designated concentrations 
enhances the osteogenic capabilities of pOBs.  These data are at variance with results indicating 
that LPS stimulation inhibits mouse osteogenesis under inflammatory conditions (Tomomatsu et 
al., 2009). 
4.3. TLR4 signaling in cocultures 
Pre-vascularization strategies based on the inclusion of endothelial cells in tissue constructs 
utilizes the natural interaction of endothelial cells with angiogenic factor-producing cells, either 
present or recruited to the regenerative niche. Several studies have previously reported that these 
pre-vascularization strategies might also be applied to promote vascularization in bone tissue 
engineering. A coculture system consisting, for example, of pOBs and OECs supports the 
formation of vascular structures in vitro and their inosculation following implantation in vivo  
(Fuchs et al., 2009).  In this study we have observed that LPS treatment enhances the formation 
of microvessels in cocultures of pOBs and OECs. The pathways that lead to this enhancement of 
microvessels have also been investigated. 
First, the levels of ICAM-1 and E-selectin, which can promote angiogenesis and support the 
survival of microvessels (Oh et al., 2007; Wu et al., 2006) increased significantly after 24 hours 
of LPS treatment. Second, LPS-EB treatment enhanced the expression of some cytokines in the 
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cocultures, such as IL-6 and IL-8, as shown by the protein arrays data. IL-6 is involved in 
angiogenesis by controlling the levels of VEGF (Hernández-Rodríguez et al., 2003; Middleton et 
al., 2014). IL-8 is known to play an important role in endothelial cell survival (Li et al., 2003) and 
exerts pro-angiogenic effects on endothelial cells (Heidemann et al., 2003).  It has been reported 
that all these three factors (IL-6, IL-8 and VEGF) are expressed on human endothelial cells and 
osteoblasts (Lee et al., 2014). Third, the level of VEGF and PDGF-BB mRNAs were also 
upregulated after LPS treatment.  In our study, we observed that VEGF is expressed in pOB 
monocultures by using immunocytochemistry. Furthermore, the level of VEGF in pOBs 
increased after LPS treatment (data not shown). All these findings provide further evidence that 
pOBs in coculture can facilitate angiogenesis/vasculogenesis. 
This study has demonstrated that TLR4 signaling through LPS-EB enhances both osteogenesis 
and angiogenesis. The positive effects are accumulative on OECs and pOBs. The knowledge 
obtained from this study should help to elucidate the role of TLR4 in 
angiogenesis/vasculogenesis in various settings related to tissue repair and tissue engineering. 
The first involves infection and other conditions involving LPS in the human body (e.g., in the 
gut) in which exogenous TLR4 ligand activates the TLR4 pathway. The second involves sterile 
inflammatory conditions in which TLR4 can be activated by endogenous TLR ligands (Taylor et 
al., 2007; Schaefer et al., 2005; Smiley et al., 2001; Okamura et al., 2001). The third involves 
biomaterial applications, as some biomaterials have been shown to activate TLR4 pathways 
(Shokouhi et al., 2010; Islam et al., 2011).  
Coculture techniques in combination with additional intervention through TLR signaling 
represent a promising approach with respect to the formation of a stable vasculature and 
osteogenic differentiation in bone engineering. New approaches simultaneously enhancing the 
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two fundamental processes in bone regeneration, namely, osteogenesis and angiogenesis could be 
of considerable therapeutic potential. According to this study, LPS and its agonists might 
improve both processes and therefore could be used for intervention in angiogenesis in vivo. 
Synthetic TLR4 agonists such as glucopyranosyl lipid adjuvant (GLA; Arias et al., 2012) or 
synthetic TLR-4 agonist peptides (Shanmugam et al., 2012), which could activate the TLR4 
signaling, should therefore be tested for their potential applications in promoting 
angiogenesis/vasculogenesis in tissue constructs in tissue engineering and regenerative medicine. 
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Figure 1 Effect of LPS-EB treatment on cocultures of OECs and pOBs. Microvessels were 
stained green with an anti-CD31 antibody. (A-C) DIV7 cocultures of OECs and pOBs were 
treated with LPS-EB (1.25 µg/ml) for 24 hours and cultivated for an additional 3 days before 
CD31 staining. (A) Microvessels in cocultures with and without LPS-EB treatment. The 
quantitation of the microvessel area in cocultures of OECs (from three donors named D1, D2, and 
D3) and pOBs is shown in the right panel. (B) Cocultures of OECs (D2) and POBs were treated 
with various concentrations of LPS-EB. The quantitation of the microvessel area is shown in (C). 
(D) DIV7 cocultures of OECs and pOBs were treated with 1.25 µg/ml LPS-EB for 96 hours and 
cultivated for an additional 3 days before anti-CD31 staining.  For each experiment, three 
representative images from cocultures were acquired and analyzed. Significance of difference 
was assessed by the p-value (*p < 0.05; **p < 0.01). Scale bars: 50 µm. 
Figure 2 Effect of LPS-EB treatment on monoculture of OECs. (A) TLR4, CD31, and cell nuclei 
are shown in red, green, and blue (DRAQ5), respectively. (B-C) OECs were treated with 1.25 
µg/ml for 24 hours and stained for TLR4, MYD88, and Ki67. The quantitation of staining is 
shown in the right panels. For each experiment, three images from cocultures were taken and 
analyzed. Significance of differences was assessed by the p-value (**p < 0.01). (D) Wound 
scratch assay used to study directional OEC migration in vitro without and with LPS-EB 
treatment (1.25 µg/ml, 24 hours).  The red lines indicate the wound closure. Representative 
images from one experiment (in total 3 experiments) are shown. Scale bars: 50 µm.  
Figure 3 Effect of LPS-EB treatment on the angiogenic potential of OECs.  (A) Tube formation 
by OECs without and with LPS-EB treatment (1.25 µg/ml, 24 hours) was evaluated by using the 
Fibrin Gel in vitro Angiogenesis Assay. (B) DIV7 OECs were treated with 1.25 µg/ml LPS-EB 
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for 24 hours and stained for angiogenic factors, namely VEGF, angiopoietin 1, and angiopoietin 
2. For each experiment, three images from cocultures were taken and analyzed. The quantitation 
of the staining is shown in the panels on the right. Significance of difference was assessed by the 
p-value (**p < 0.01). Representative images from one experiment (in total 3 experiments) are 
shown. Scale bars: 50 µm. 
Figure 4 Effect of LPS-EB treatment on the reorganization of OECs and their actin filaments. 
(A)  The actin filaments in OECs were reorganized after treatment with 1.25 µg/ml LPS-EB for 
24 hours. The white arrow indicates the peripheral accumulation of actin filaments (“peripheral 
ring”).  (B) Three cropped regions from (A, right panel) show different types of reorganization of 
actin filaments at higher resolution. 
Figure 5 Effect of LPS-EB treatment on monocultures of pOBs. (A) TLR4 and F-actin (stained 
with phalloidin) are shown in red and green, respectively.  (B-D) POBs were treated with 1.25 
µg/ml LPS-EB for 24 hours and stained for TLR4, MYD88, Ki67, and osteogenic markers, 
namely osteocalcin and osteonectin. The quantitation of the staining is shown in the panels on the 
right. For each experiment, three images from cocultures were acquired and analyzed.  
Significance of difference was assessed by the p-value (**p < 0.01). Scale bars: 50 µm. 
Figure 6 Inflammatory and angiogenic factors in the cocultures of pOB and OECs were 
upregulated after LPS-EB treatment. DIV7 cocultures of OECs and POBs were treated with LPS-
EB for 24 hours. (A) The concentrations of ICAM1, E-Selectin, IL-6, and IL-8 were measured by 
using ELISA. Significance of differences was assessed by the p-value (*p < 0.05). n=3. (B) The 
relative gene expression of VEGF and PDGF-BB was measured by using RT-PCR. GADPH was 
taken as an endogenous standard and control cultures were set to 1.  
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S Figure 1 Angiogenesis factors, namely angiopoietin 1 and angiopoietin 2, were upregulated in 
monocultures of OECs.  OECs at low cell density were treated with 1.25 µg/ml LPS-EB for 24 
hours and stained for Angiopoietin 1 and Angiopoietin 2. Scale bars: 50 µm. 
 S Figure 2 TLR4 expression in monocultures of pOBs shown at higher resolution (cropped 
region of Figure 5A).  TLR4 and actin are shown in red and green, respectively.  
 
 








